Megestrol

• Description:

  Megestrol is a synthetic progestin and used for the treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with an acquired immunodeficiency syndrome diagnosis[1].

• UNSPSC:

  12352211

• Hazard Statement:

  H361

• Target:

  Drug Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Inflammation/Immunology; Cancer

• Assay Protocol:

  https://www.medchemexpress.com/megestrol.html

• Purity:

  99.44

• Solubility:

  DMSO : 70 mg/mL (ultrasonic)

• Smiles:

  CC ([C@@]1 (O) CC[C@@]2 ([H]) [C@]3 ([H]) C=C (C) C4=CC (CC[C@]4 (C) [C@@]3 ([H]) CC[C@]12C) =O) =O

• Molecular Formula:

  C22H30O3

• Molecular Weight:

  342.48

• Precautions:

  H361

• References & Citations:

  [1]Garcia JM, et al. Off-Label Megestrol in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments. Am J Med. 2018 Jun;131 (6) :623-629.e1.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  Launched

• CAS Number:

  3562-63-8